Towards Evidence-Based Management of Inherited Breast and Breast-Ovarian Cancer

Por Møller Pål
Publicado em 2004-12-01

Towards Evidence-Based Management of Inherited Breast and Breast-Ovarian Cancer

Por Møller, Pål
Publicado em 2004

The Prospective Lynch Syndrome Database reports enable evidence-based personal precision health care

Por Møller, Pål
Publicado no Hered Cancer Clin Pract (2020)

The BRCA2 variant c.68-7 T>A is associated with breast cancer

Por Møller, Pål, Hovig, Eivind
Publicado no Hered Cancer Clin Pract (2017)

Retraction Note to: The BRCA2 variant c.68–7 T > A is associated with breast cancer

Por Møller, Pål, Hovig, Eivind
Publicado no Hered Cancer Clin Pract (2018)

Our genes, our selves: hereditary breast cancer and biological citizenship in Norway

Por Møller, Pål, Hovig, Eivind
Publicado no Med Health Care Philos (2017)

Costs and Benefits of Diagnosing Familial Breast Cancer

Por Heimdal, Ketil, Mæhle, Lovise, Møller, Pål
Publicado em 1999

MRI screening of women with hereditary predisposition to breast cancer: diagnostic performance and survival analysis

Por Tharmaratnam, Kukatharmini, Hagen, Anne Irene, Møller, Pål
Publicado no Breast Cancer Res Treat (2014)

No Sib Pair Concordance for Breast or Ovarian Cancer in BRCA1 Mutation Carriers

Por Møller, Pål, Mæhle, Lovise, Clark, Neal, Apold, Jaran
Publicado em 2007

Uptake of Genetic Testing and Pre-Test Levels of Mental Distress in Norwegian Families with Known BRCA1 Mutations

Por Reichelt, Jon G., Dahl, Alv A., Heimdal, Ketil, Møller, Pål
Publicado em 1999

Causes for Frequent Pathogenic BRCA1 Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift

Por Møller, Pål, Dominguez-Valentin, Mev, Rødland, Einar Andreas, Hovig, Eivind
Publicado no Cancers (Basel) (2019)

Correction: Møller, P.; et al. Causes for Frequent Pathogenic BRCA1 Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift. Cancers 2019, 11...

Por Møller, Pål, Dominguez-Valentin, Mev, Rødland, Einar Andreas, Hovig, Eivind
Publicado no Cancers (Basel) (2020)

Prospective observational data informs understanding and future management of Lynch syndrome: insights from the Prospective Lynch Syndrome Database (PLSD)

Por Seppälä, Toni T., Dominguez-Valentin, Mev, Sampson, Julian R., Møller, Pål
Publicado no Fam Cancer (2020)

MUTYH Mutations Do Not Cause HNPCC or Late Onset Familial Colorectal Cancer

Por Stormorken, Astrid, Heintz, Karen-Marie, Andresen, Per Arne, Hovig, Eivind, Møller, Pål
Publicado em 2006

BRCA1 1675delA and 1135insA Account for One Third of Norwegian Familial Breast-Ovarian Cancer and Are Associated with Later Disease Onset than Less Frequent Mutations

Por Borg, Åke, Dørum, Anne, Heimdal, Ketil, Mæhle, Lovise, Hovig, Eivind, Møller, Pål
Publicado em 1999

Survival in Norwegian BRCA1 mutation carriers with breast cancer

Por Hagen, Anne Irene, Tretli, Steinar, Mæhle, Lovise, Apold, Jaran, Vedå, Nina, Møller, Pål
Publicado em 2009

Ten modifiers of BRCA1 penetrance validated in a Norwegian series

Por Heramb, Cecilie, Ekstrøm, Per Olaf, Tharmaratnam, Kukatharmini, Hovig, Eivind, Møller, Pål, Mæhle, Lovise
Publicado no Hered Cancer Clin Pract (2015)

Germline PTEN mutations are rare and highly penetrant

Por Rustad Cecilie F, Bjørnslett Merete, Heimdal Ketil R, Mæhle Lovise, Apold Jaran, Møller Pål
Publicado em 2006-12-01

Germline PTEN mutations are rare and highly penetrant

Por Rustad, Cecilie F, Bjørnslett, Merete, Heimdal, Ketil R, Mæhle, Lovise, Apold, Jaran, Møller, Pål
Publicado em 2006

The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation

Por Møller, Pål, Stormorken, Astrid, Holmen, Marit Muri, Hagen, Anne Irene, Vabø, Anita, Mæhle, Lovise
Publicado em 2014